Identification of determinants of high-fidelity DNA synthesis in Mycobacterium smegmatis DnaE1 through in silico and in vivo approaches
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf1274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Rosan C M Kuin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal chemistry, Leiden University,Einsteinweg 55, 2333 CC Leiden, the Netherlands. Hauptthemen laut MEDLINE: Mycobacterium smegmatis, DNA Replication, DNA Polymerase III, Bacterial Proteins. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Delta Program 'AI for Computational Life Sciences', Medical Delta Program ‘AI for Computational Life Sciences’.
Abstract (Originalsprache)
Drug resistance in Mycobacterium tuberculosis presents a major challenge in tuberculosis treatment, highlighting the need to understand the underlying mechanisms. DNA replication plays an important role in the acquisition of drug resistance, and the expression of the DNA polymerase DnaE2 during adverse conditions has been associated with increased mutation rates. Here, we investigate the functional differences between the high-fidelity replicative DNA polymerase DnaE1 and the predicted error-prone DNA polymerase DnaE2, focusing on which amino acid changes affect polymerase fidelity. For this, we identify potential fidelity-altering positions using a two-entropies sequence analysis combined with experimental validation to test whether changes of these positions affect the mutation rates. We find that a double mutation in the palm domain of Mycobacterium smegmatis DnaE1: D431S/R432D, increases mutation frequencies both in vivo and in vitro. The location of these two residues adjacent to the DNA backbone of the template strand suggests that the amino acid change results in a looser grip on the DNA, allowing for the incorporation of incorrect nucleotides. These insights improve our understanding of the mechanisms underlying drug resistance in M. tuberculosis and could help in the development of future strategies to combat it.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medicinal chemistry, Leiden University,Einsteinweg 55, 2333 CC Leiden, the Netherlands.
- Department of Cell and Chemical Biology, Leiden University Medical Center,Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
ORCID-Profile: Meindert H Lamers
Förderung
- Medical Delta Program 'AI for Computational Life Sciences'
- Medical Delta Program ‘AI for Computational Life Sciences’
Zitieren
APA
Kuin, R. C. M., van Westen, G. J. P., & Lamers, M. H. (2025). Identification of determinants of high-fidelity DNA synthesis in Mycobacterium smegmatis DnaE1 through in silico and in vivo approaches. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1274
Vancouver
Kuin RCM, van Westen GJP, Lamers MH. Identification of determinants of high-fidelity DNA synthesis in Mycobacterium smegmatis DnaE1 through in silico and in vivo approaches. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf1274
BibTeX
@article{Kuin2025,
author = {Kuin, Rosan C M and van Westen, Gerard J P and Lamers, Meindert H},
title = {Identification of determinants of high-fidelity DNA synthesis in Mycobacterium smegmatis DnaE1 through in silico and in vivo approaches},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf1274}
}
EUVIMED